First Psychedelics Company Goes Public, Phase III Clinical Trials On MDMA For PTSD

MindMed Became the First Psychedelics Company to List Publicly on NEO Stock Exchange, Created New Committee Mind Medicine Inc. MMEDF 13.64% (NEO: MMED) received clearance by Canada’s NEO Exchange to list under the symbol [...]